Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Lancet 2001

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Lancet.

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Nobaek S, Johansson ML, Molin G,

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi

Saccharomyces boulardii in maintenance treatment of Crohn's disease. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Dig Dis Sci. 2000 Jul;45(7):1462-4. אחד האתגרים העומדים בפני

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Surawicz CM, McFarland LV, Greenberg RN,

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali

Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. J Pediatr. 2001 Mar;138(3):361-5.